Advertisement
Medtronic
Subscribe to Medtronic

The Lead

Medtronic Drug-Coated Balloon for Improved Treatment of Peripheral Artery Disease

September 16, 2014 9:55 am | by Medtronic | News | Comments

Presented for the first time at the 2014 Transcatheter Cardiovascular Therapeutics (TCT) conference, the latest clinical and economic data on the IN.PACT Admiral drug-coated balloon (DCB) from Medtronic, Inc. augments an already robust body of...

Type 2 Diabetes Patients Achieve Greater Satisfaction with Insulin Pumps vs. Multiple Daily Injections

September 16, 2014 9:44 am | by Medtronic | News | Comments

Medtronic, Inc. today announced that new results from the OpT2mise trial are being...

Medtronic Launches SEEQ Wearable Cardiac Monitoring System in United States

September 15, 2014 10:18 am | by Medtronic | News | Comments

Medtronic, Inc. has announced the U.S. launch of the SEEQ Mobile Cardiac Telemetry (MCT) System...

Medtronic’s CoreValve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients

September 15, 2014 10:14 am | by Medtronic | News | Comments

Medtronic, Inc. has announced new data showing that transcatheter aortic valve replacement (TAVR...

View Sample

FREE Email Newsletter

Medtronic NC Euphora Coronary Balloon Receives FDA Clearance

September 11, 2014 9:58 am | by Medtronic | News | Comments

Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and launch of the NC Euphora Noncompliant Balloon Dilatation Catheter. The new device will be featured for the first time in the United States at the...

First U.S. Implants in Clinical Study of Medtronic’s Recapturable CoreValve Evolut R

September 10, 2014 9:39 am | by Medtronic | News | Comments

Medtronic, Inc. has announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate the safety and effectiveness of the new Medtronic CoreValve Evolut R System. This novel investigational self-expanding valve...

Medtronic Receives Clearance for the SHILLA Growth Guidance System

August 28, 2014 11:04 am | by Medtronic, Inc. | News | Comments

Medtronic, Inc. today announced the 510(k) clearance and launch of the SHILLA(TM) Growth Guidance System. The system is designed for treatment of skeletally immature pediatric patients less 10 years of age diagnosed with severe, progressive...

Advertisement

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

August 27, 2014 12:10 pm | by The Associated Press | News | Comments

Medtronic, Inc. has announced the first implants in a clinical trial that will compare patient and healthcare system outcomes - including patient mortality and hospitalizations - in heart failure patients who have cardiac resynchronization...

Medtronic Acquires NGC Medical to Strengthen Its Integrated Health Solutions Portfolio

August 27, 2014 9:16 am | by The Associated Press | News | Comments

Medtronic, Inc. has announced that it has completed the acquisition of NGC Medical S.p.A. (NGC), a privately-held Italian company, in a transaction that values NGC at $350 million. Medtronic held a 30 percent ownership stake in the company...

Medtronic Acquires Sapiens Steering Brain Stimulation

August 26, 2014 12:08 pm | by Medtronic, Inc. | News | Comments

Medtronic, Inc. today announced that it has acquired Sapiens Steering Brain Stimulation (Sapiens SBS), a privately held developer of deep brain stimulation (DBS) technologies for approximately $200 million in an all-cash transaction. The...

Medtronic’s Viva Cardiac Resynchronization Therapy-Pacemaker Approved in U.S.

August 25, 2014 10:26 am | by Medtronic | News | Comments

Medtronic, Inc. has announced the U.S. Food and Drug Administration (FDA) approval of its newest cardiac resynchronization therapy-pacemaker, Viva CRT-P, for indicated patients with heart failure or atrioventricular (AV) block. The Viva CRT-P...

Tax Savings Not Only Benefit to Medtronic-Covidien Deal

August 19, 2014 10:37 am | by The Associated Press | News | Comments

US-based Medtronic said it would purchase Ireland-based Covidien for $42.9 billion, combining two of the world's biggest medical device makers and helping Medtronic savings with a headquarters change.  Kalorama estimates the deal will come...

Advertisement

FDA Approval for Medtronic’s Attain Performa Quadripolar Lead and Viva Quad CRT-Ds

August 7, 2014 9:47 am | by Medtronic | News | Comments

Medtronic, Inc. has announced it has received United States Food and Drug Administration (FDA) approval for the Attain Performa Model 4298 quadripolar lead, and the Viva Quad XT and Viva Quad S cardiac resynchronization therapy defibrillators...

Medtronic Launches NuVent EM Sinus Dilation System for Fusion ENT Navigation System

August 4, 2014 8:36 am | by Medtronic | News | Comments

Medtronic Inc. has announced the launch of the NuVent EM Sinus Dilation System for the Fusion ENT Navigation System, developed and manufactured by the company's Ear Nose and Throat (ENT) division of its Surgical Technologies business. NuVent...

Infographic: Insulin Pumps Beat Injections in Type 2 Diabetes Management

July 7, 2014 11:17 am | by Medtronic | News | Comments

In the OpT2mise trial, those using insulin pumps achieved a mean A1C (average blood glucose) reduction of 1.1 percent compared to only a 0.4 percent reduction by those using multiple daily injections. This improvement in glucose control was...

Type 2 Diabetes Patients Achieve Superior Outcomes with Insulin Pumps vs. Multiple Daily Injections

July 7, 2014 11:17 am | by Medtronic | News | Comments

As an example of its commitment to improving clinical outcomes for all people with diabetes, Medtronic, Inc. has announced the results of the OpT2mise trial, which showed that MiniMed insulin pumps safely achieve better glucose control for...

This Rainbow Leads to New Medical Innovations

June 27, 2014 2:45 pm | by Bloomberg | Videos | Comments

Efi Cohen-Arazi, co-founder and Chief Executive Officer at Rainbow Medical, talks with Elliott Gotkine about innovations to help those who have lost their vision and their partnership with Medtronic on a nerve stimulation product. He speaks...

Advertisement

Insertable Cardiac Monitors Detect Afib in Stroke Patients Better Than Standard Care

June 26, 2014 9:34 am | by Medtronic | News | Comments

Medtronic Inc. has announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial Fibrillation) Clinical Trial have been published in The New England Journal of Medicine. The Trial found that continuous cardiac monitoring...

GlobalData Analysts: Strategic Benefits, Not Tax Avoidance, the Main Motivation for Medtronic Megadeal

June 24, 2014 2:08 pm | by GlobalData | News | Comments

Medtronic’s $42.9 billion merger with Covidien, which created last week the world’s largest medical devices company, was primarily motivated by future market gains rather than tax inversion, according to analysts with research and consulting...

Medtronic Announces Preliminary Outcomes for World’s Smallest Cardiac Pacemaker

June 19, 2014 2:48 pm | by Medtronic | News | Comments

Medtronic, Inc. has announced preliminary results from the first human implants of the world’s smallest pacemaker, the Micra Transcatheter Pacing System (TPS). Results from the first four patients to receive the Micra TPS were reported at...

Tax Savings Not Only Benefit to Medtronic-Covidien Deal

June 18, 2014 3:53 pm | by Kalorama | News | Comments

U.S.-based Medtronic said it would purchase Ireland-based Covidien for $42.9 billion, combining two of the world’s biggest medical device makers and helping Medtronic savings with a headquarters change. Kalorama estimates the deal will come...

Medtronic to Buy Covidien

June 16, 2014 9:10 am | by Josh Boak, AP Business Writer | News | Comments

U.S. medical device manufacturer Medtronic has agreed to buy Ireland-based competitor Covidien for $42.9 billion in cash and stock. The combined company would have its executive offices in Dublin, where it could benefit from Ireland's lower...

Medtronic Heart Valve Approved for Broader Use

June 13, 2014 11:14 am | by The Associated Press | News | Comments

Medtronic Inc. said Thursday that the FDA approved its artificial heart valve, CoreValve, for use in more patients who face serious risks from open-heart surgery, the standard treatment. Medtronic's implant is a less invasive approach to...

World's First Combined Glucose Sensor and Insulin Infusion Set for Diabetics Launches

June 3, 2014 10:37 am | by Medtronic | News | Comments

Medtronic, Inc. has announced the European launch of MiniMed Duo, the world's first two-in-one breakthrough that combines a glucose sensor and insulin infusion set into one on-body device, simplifying integrated insulin pump therapy and...

Medtronic Unveils Online Community to Connect People with Medical Devices Who ‘Live On. Give On.’

June 2, 2014 11:24 am | by Medtronic | News | Comments

Medtronic, Inc. today opened 2014 award applications for the Bakken Invitation, a global program designed to celebrate and connect people who, with the help of medical technology, have overcome health challenges and are now selflessly giving...

Medtronic Launches Advisa and Ensura SR MRI SureScan Pacemaker Systems in Europe

June 2, 2014 10:22 am | by Medtronic | News | Comments

Medtronic, Inc., today announced CE (Conformité Européenne) Mark and commercial launch of the Advisa and Ensura SR MRI SureScan single chamber pacemaker devices in Europe. Both pacemakers are approved for magnetic resonance imaging (MRI)...

Report on Medical Device Market Outlines Challenges, Opportunities for Cost Containment

May 30, 2014 3:44 pm | by Rich Gedney, CEO, ADMET | Admet, Inc. | Blogs | Comments

The medical device market has experienced tremendous growth, reaching more than $330 billion worldwide. While the industry remains healthy, several challenges face those who design and manufacture medical devices. ADMET serves this market...

Medtronic Settles Whistleblower Lawsuit for $9.9M

May 29, 2014 3:19 pm | by The Associated Press | News | Comments

Medical device maker Medtronic Inc. will pay the U.S. Department of Justice $9.9 million to settle a lawsuit that accused the company of giving doctors gifts in return for using its defibrillators and pacemakers. Medtronic has not admitted...

Understanding and Treating Networks of the Brain

May 27, 2014 10:49 am | by DARPA | News | Comments

Work on DARPA’s Systems-Based Neurotechnology for Emerging Therapies (SUBNETS) program is set to begin with teams led by UC San Francisco (UCSF), and Massachusetts General Hospital (MGH). The SUBNETS program seeks to reduce the severity...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading